FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

Plus, news about vTv Therapeutics, Dynavax, Aura Biosciences and ArkBio: FDA lifts hold on Scynexis’ Phase 3 fungal infection trial: The agency concluded last month that the MARIO trial of ibrexafungerp ...